SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001213900-21-044137
Filing Date
2021-08-23
Accepted
2021-08-23 06:07:23
Documents
2
Period of Report
2021-09-27

Document Format Files

Seq Description Document Type Size
1 PROXY def14a0821_adialpharm.htm DEF 14A 1143203
2 GRAPHIC tadial_logo.jpg GRAPHIC 138070
  Complete submission text file 0001213900-21-044137.txt   1334758
Mailing Address 1180 SEMINOLE TRAIL SUITE 495 CHARLOTTESVILLE VA 22901
Business Address 1180 SEMINOLE TRAIL SUITE 495 CHARLOTTESVILLE VA 22901 434-422-9800
ADIAL PHARMACEUTICALS, INC. (Filer) CIK: 0001513525 (see all company filings)

IRS No.: 800667150 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-38323 | Film No.: 211195306
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences